Package Leaflet: Information for the User
Ibuprofen Codramol 200 mg Oral Suspension
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet:
Ibuprofen, the active ingredient of this medicine, acts by reducing pain and fever.
This medicine is used in adults and children from 7 years old for the symptomatic relief of occasional mild or moderate pain, as well as febrile conditions.
Do not take Ibuprofen Codramol:
if you have previously had a stomach or duodenal ulcer or have suffered a perforation of the digestive tract.
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine.
Tell your doctor:
Cardiovascular Precautions
Anti-inflammatory/analgesic medicines like ibuprofen may be associated with a small increased risk of suffering a heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration.
You should discuss your treatment with your doctor or pharmacist before taking this medicine if:
Similarly, this type of medicine may cause fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
Skin Reactions
Severe skin reactions have been reported with Ibuprofeno Winadol treatment. Stop taking Ibuprofeno Winadol and consult a doctor immediately if you experience any skin rash, lesions on the mucous membranes, blisters, or other signs of allergy, as these may be the first signs of a very severe skin reaction. See section 4.
Children and Adolescents
There is a risk of kidney damage in dehydrated children and adolescents.
Taking Ibuprofeno Codramol with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medicine, including those obtained without a prescription.
The following medicines may interfere and should not be taken with ibuprofen without first consulting your doctor:
Other medicines may also affect or be affected by treatment with ibuprofen. Therefore, you should always consult your doctor or pharmacist before using ibuprofen with other medicines.
Interference with analytical tests
If you are going to undergo any diagnostic test (including blood tests, urine tests, skin tests that use allergens, etc.), tell your doctor that you are taking this medicine, as it may alter the results.
Taking Ibuprofeno Codramol with food, drinks, and alcohol
You can take it alone or with food. In general, it is recommended to take it before meals to reduce the possibility of stomach upset.
If you drink alcohol while taking this medicine, you may be more prone to side effects.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Do not take ibuprofen if you are in the last 3 months of pregnancy, as it may harm the fetus or cause problems during delivery. It may cause kidney and heart problems in your fetus. It may affect your and your baby's tendency to bleed and delay or prolong labor more than expected. You should not take ibuprofen during the first 6 months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time. From the 20th week of pregnancy, Ibuprofeno Codramol may cause kidney problems in your fetus if taken for more than a few days, which may cause low levels of amniotic fluid surrounding the baby (oligohydramnios). If you need treatment for more than a few days, your doctor may recommend additional checks.
Precautions during pregnancy and in women of childbearing age
Pregnancy
Because the administration of medicines of this type has been associated with an increased risk of congenital anomalies/abortions, it is not recommended to administer it during the first and second trimester of pregnancy unless it is strictly necessary. In these cases, the dose and duration will be limited to the minimum possible.
In the third trimester, administration is contraindicated
Fertility
For patients of childbearing age, it should be taken into account that medicines like ibuprofen have been associated with a decrease in fertility.
Breastfeeding
Although the levels of the medicine in breast milk are negligible, it is recommended to consult a doctor in cases of long-term treatment or high doses during breastfeeding.
Driving and using machines
If you experience dizziness, vertigo, vision changes, or other symptoms while taking this medicine, you should not drive or operate machinery. If you only take one dose of ibuprofen or for a short period, it is not necessary to take special precautions.
Ibuprofeno Codramol contains sodium and liquid maltitol (E-965)
Patients on low-sodium diets should note that this medicine contains 35.84 mg (1.6 mmol) of sodium per sachet.
This medicine contains liquid maltitol (E-965). If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Follow the administration instructions of the medicine contained in this prospectus as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
It is essential to always take the smallest dose that relieves the pain and not take the medicine for longer than necessary to control your symptoms.
The effective lowest dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult a doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
Dosage
Pediatric population
The dose of ibuprofen to be administered depends on the age and weight of the child. As a general rule, the recommended daily dose is 20 to 30 mg/kg of weight, divided into three or four individual doses.
In general, the following dosage guideline is recommended:
The interval between doses will depend on the evolution of symptoms, but it will never be less than 4 hours.
The use of this medicine is not recommended in children with a weight of less than 25 kg (approximately 7 years old) since the dose (200 mg of ibuprofen) does not adapt to the recommended dosage in these patients.
Adults:
The recommended dose is 1 to 2 sachets (200-400 mg of ibuprofen) every 4-8 hours, depending on the intensity of symptoms and response to treatment. Do not take more than 6 sachets (1200 mg) within 24 hours.
Patients with kidney, liver, or heart disease:
In patients with mild or moderate disease, the initial dose should be reduced. Ibuprofen should not be used in patients with severe renal, hepatic, or cardiac insufficiency.
If symptoms worsen, if fever persists for more than 3 days or pain for more than 5 days (3 days in children and adolescents), consult a doctor.
The administration of this medicine is subject to the appearance of pain or fever. As they disappear, the medication should be suspended.
Method of administration
This medicine is a suspension, administered orally.
It is necessary to homogenize the suspension immediately before taking it, as indicated in the following figure:
1 – Press the top and bottom of the sachet with your fingers several times
2 – Press from top to bottom and vice versa for a minimum of 30 seconds
It can be taken directly from the sachet or diluted in water.
In case of digestive discomfort, it is recommended to take the medicine with meals.
If you take more Ibuprofeno Codramol than you should
If you have taken more ibuprofen than you should or have accidentally ingested the contents of the package, consult your doctor or pharmacist or the Toxicology Information Service, phone: 91 5620420, indicating the medicine and the amount ingested. It is recommended to bring the package and the prospectus of the medicine to the healthcare professional.
If you have taken more Ibuprofeno Codramol than you should, or if a child has accidentally ingested the medicine, consult a doctor or go to the nearest hospital to find out about the risk and ask for advice on the measures to be taken.
Symptoms of overdose may include nausea, stomach pain, vomiting (which may contain bloody sputum), headache, ringing in the ears, confusion, and involuntary eye movement. At high doses, symptoms of drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, chills, and breathing difficulties have been reported. It is rare for more severe symptoms to appear, such as intestinal bleeding, low blood pressure, low body temperature, metabolic acidosis, convulsions, altered kidney function, coma, adult respiratory distress, and transient respiratory arrest in children (after ingesting large amounts).
If a severe poisoning has occurred, the doctor will take the necessary measures.
If you forget to take Ibuprofeno Codramol
Do not take a double dose to make up for forgotten doses.
If you forget to take your corresponding dose, take it as soon as you remember. However, if the time of the next dose is very close, skip the forgotten dose and take the next dose at the usual time.
If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
The incidence of adverse effects is lower in short-term treatments and if the daily dose is below the maximum recommended dose.
The frequencies shown below refer to the short-term use of maximum daily doses of up to 1200 mg of oral ibuprofen:
Disorientation or confusion, depression, vertigo, tinnitus (ringing or sounds in the ear), reversible toxic amblyopia, liver damage, edema (swelling caused by fluid accumulation in tissues), optic neuritis.
Pancreatitis, severe bullous reactions including Stevens-Johnson syndrome (widespread erosions affecting the skin and at least two mucous membranes) and toxic epidermal necrolysis (erosions on mucous membranes and painful lesions with necrosis and shedding of the epidermis), erythema multiforme (skin lesion). In case of severe generalized hypersensitivity reaction, signs may include facial swelling, tongue and larynx swelling, shortness of breath, tachycardia, hypotension (anaphylaxis, angioedema, or severe shock), aseptic meningitis (inflammation of the meninges, which are the membranes that protect the brain and spinal cord, not caused by bacteria). In most cases where aseptic meningitis has been reported with ibuprofen, the patient suffered from some form of autoimmune disease (such as systemic lupus erythematosus and other collagen diseases), which was a risk factor. The symptoms of aseptic meningitis observed were neck stiffness, headache, nausea, vomiting, fever, or disorientation. Other very rare adverse effects are decreased platelets, decreased white blood cells (which may manifest as frequent infections with fever, chills, or sore throat), decreased red blood cells (which may manifest as difficulty breathing and pale skin), neutropenia (decrease in neutrophils), and agranulocytosis (significant decrease in neutrophils), aplastic anemia (bone marrow failure to produce different types of cells), hemolytic anemia (premature destruction of red blood cells). The first symptoms are: fever, sore throat, superficial ulcers in the mouth, pseudo-flu symptoms, extreme fatigue, bleeding, and bruises of unknown cause. Severe liver failure, heart failure, myocardial infarction, hypertension. Tubulointerstitial nephritis (kidney disorder), nephrotic syndrome (disorder characterized by protein in the urine and body swelling), and renal failure (sudden loss of kidney function), acute kidney failure, and papillary necrosis (especially with prolonged use) associated with increased urea.
Exacerbation of inflammation-related infections has been observed coinciding with the use of NSAIDs. If signs of infection or worsening of symptoms occur during the use of ibuprofen, it is recommended to consult a doctor as soon as possible.
Colitis and Crohn's disease (chronic disease in which the immune system attacks the intestine, causing inflammation that usually produces bloody diarrhea).
Generalized red scaly rash, with bumps under the skin and blisters located mainly in skin folds, trunk, and upper limbs, accompanied by fever at the start of treatment (acute generalized exanthematous pustulosis). Stop taking Ibuprofeno Codramol if you experience these symptoms and seek immediate medical attention. See also section 2.
The skin becomes sensitive to light.
A severe skin reaction known as DRESS syndrome can occur. The symptoms of DRESS syndrome include: skin rash, lymph node inflammation, and elevated eosinophils (a type of white blood cell).
If any of the following adverse effects occur, discontinue treatment and consult your doctor immediately:
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines, www.notificaRAM.es.
Keep this medicine out of sight and reach of children.
Store below 30°C.
Do not use this medicine after the expiration date shown on the package after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through wastewater or household waste. Deposit the packages and medicines you no longer need in the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of packages and medicines you no longer need. This will help protect the environment.
Composition of Ibuprofeno Codramol
Appearance of the product and package contents
Ibuprofeno Codramol is a white oral suspension with a strawberry flavor, contained in 10 ml monodose sachets formed by a polyester, aluminum, polyester, and polyethylene complex.
It is available in packages of 12 units or 20 units.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
NUTRA ESSENTIAL OTC, S.L.
C/ La Granja 1, 3ºB
28108 Alcobendas (Madrid)
Manufacturer
ALCALA FARMA, S.L.
Avenida de Madrid, 82
28802 Alcalá de Henares (Madrid)
“or”
ZINEREO PHARMA, S.L.U.
A Relva, s/n, O Porriño,
36410 Pontevedra
“or”
FARMALIDER, S.A.
C/Aragoneses, 2
28108 Alcobendas (Madrid)
“or”
EDEFARM S.L.
Polígono Industrial Enchilagar del Rullo, 117
46191 Villamarchante (Valencia)
Date of the last revision of this prospectus: November 2024
Detailed and updated information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/